These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 23837744)

  • 21. Effects of VU0410120, a novel GlyT1 inhibitor, on measures of sociability, cognition and stereotypic behaviors in a mouse model of autism.
    Burket JA; Benson AD; Green TL; Rook JM; Lindsley CW; Conn PJ; Deutsch SI
    Prog Neuropsychopharmacol Biol Psychiatry; 2015 Aug; 61():10-7. PubMed ID: 25784602
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and SAR of GlyT1 inhibitors derived from a series of N-((4-(morpholine-4-carbonyl)-1-(propylsulfonyl)piperidin-4-yl)methyl)benzamides.
    Zhao Z; O'Brien JA; Lemaire W; Williams DL; Jacobson MA; Sur C; Pettibone DJ; Tiller PR; Smith S; Hartman GD; Wolkenberg SE; Lindsley CW
    Bioorg Med Chem Lett; 2006 Dec; 16(23):5968-72. PubMed ID: 16987662
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of SSR103800, a selective inhibitor of the glycine transporter-1 in models predictive of therapeutic activity in schizophrenia.
    Boulay D; Pichat P; Dargazanli G; Estenne-Bouhtou G; Terranova JP; Rogacki N; Stemmelin J; Coste A; Lanneau C; Desvignes C; Cohen C; Alonso R; Vigé X; Biton B; Steinberg R; Sevrin M; Oury-Donat F; George P; Bergis O; Griebel G; Avenet P; Scatton B
    Pharmacol Biochem Behav; 2008 Nov; 91(1):47-58. PubMed ID: 18621075
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design, synthesis, and SAR of N-((1-(4-(propylsulfonyl)piperazin-1-yl)cycloalkyl)methyl)benzamide inhibitors of glycine transporter-1.
    Cioffi CL; Wolf MA; Guzzo PR; Sadalapure K; Parthasarathy V; Dethe D; Maeng JH; Carulli E; Loong DT; Fang X; Hu M; Gupta P; Chung M; Bai M; Moore N; Luche M; Khmelnitsky Y; Love PL; Watson MA; Mhyre AJ; Liu S
    Bioorg Med Chem Lett; 2013 Mar; 23(5):1257-61. PubMed ID: 23380375
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and characterization of [¹²⁵I]2-iodo N-[(S)-{(S)-1-methylpiperidin-2-yl}(phenyl)methyl]3-trifluoromethyl-benzamide as novel imaging probe for glycine transporter 1.
    Fuchigami T; Haratake M; Magata Y; Haradahira T; Nakayama M
    Bioorg Med Chem; 2011 Nov; 19(21):6245-53. PubMed ID: 21975065
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discovery of N-(2-aryl-cyclohexyl) substituted spiropiperidines as a novel class of GlyT1 inhibitors.
    Pinard E; Ceccarelli SM; Stalder H; Alberati D
    Bioorg Med Chem Lett; 2006 Jan; 16(2):349-53. PubMed ID: 16246557
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The discovery of a structurally novel class of inhibitors of the type 1 glycine transporter.
    Lowe JA; Hou X; Schmidt C; David Tingley F; McHardy S; Kalman M; Deninno S; Sanner M; Ward K; Lebel L; Tunucci D; Valentine J; Bronk BS; Schaeffer E
    Bioorg Med Chem Lett; 2009 Jun; 19(11):2974-6. PubMed ID: 19410451
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discovery of benzoylpiperazines as a novel class of potent and selective GlyT1 inhibitors.
    Pinard E; Alberati D; Borroni E; Fischer H; Hainzl D; Jolidon S; Moreau JL; Narquizian R; Nettekoven M; Norcross RD; Stalder H; Thomas AW
    Bioorg Med Chem Lett; 2008 Sep; 18(18):5134-9. PubMed ID: 18752953
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 3-phenyl-6-(2-pyridyl)methyloxy-1,2,4-triazolo[3,4-a]phthalazines and analogues: high-affinity gamma-aminobutyric acid-A benzodiazepine receptor ligands with alpha 2, alpha 3, and alpha 5-subtype binding selectivity over alpha 1.
    Carling RW; Moore KW; Street LJ; Wild D; Isted C; Leeson PD; Thomas S; O'Connor D; McKernan RM; Quirk K; Cook SM; Atack JR; Wafford KA; Thompson SA; Dawson GR; Ferris P; Castro JL
    J Med Chem; 2004 Mar; 47(7):1807-22. PubMed ID: 15027873
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of glycine transporter 1 attenuates nicotine- but not food-induced cue-potentiated reinstatement for a response previously paired with sucrose.
    Uslaner JM; Drott JT; Sharik SS; Theberge CR; Sur C; Zeng Z; Williams DL; Hutson PH
    Behav Brain Res; 2010 Feb; 207(1):37-43. PubMed ID: 19799936
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glycine transporter 1 (GlyT1) inhibitors exhibit anticonvulsant properties in the rat maximal electroshock threshold (MEST) test.
    Kalinichev M; Starr KR; Teague S; Bradford AM; Porter RA; Herdon HJ
    Brain Res; 2010 May; 1331():105-13. PubMed ID: 20303337
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acylglycinamides as inhibitors of glycine transporter type 1.
    Blunt R; Porter R; Johns A; Nash D; Puckey G; Wyman P; Herdon H; Teague S; Hadden V; Fontana S; Gordon L
    Bioorg Med Chem Lett; 2011 Oct; 21(20):6176-9. PubMed ID: 21889344
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis of some new s-alkylated 1,2,4-triazoles, their mannich bases and their biological activities.
    Alam MM; Nazreen S; Haider S; Shafi S; Yar MS; Hamid H; Alam MS
    Arch Pharm (Weinheim); 2012 Mar; 345(3):203-14. PubMed ID: 22045469
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 1H-1,2,3-triazol-1-yl thiodigalactoside derivatives as high affinity galectin-3 inhibitors.
    Salameh BA; Cumpstey I; Sundin A; Leffler H; Nilsson UJ
    Bioorg Med Chem; 2010 Jul; 18(14):5367-78. PubMed ID: 20538469
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structure-based design and subsequent optimization of 2-tolyl-(1,2,3-triazol-1-yl-4-carboxamide) inhibitors of p38 MAP kinase.
    Cogan DA; Aungst R; Breinlinger EC; Fadra T; Goldberg DR; Hao MH; Kroe R; Moss N; Pargellis C; Qian KC; Swinamer AD
    Bioorg Med Chem Lett; 2008 Jun; 18(11):3251-5. PubMed ID: 18462940
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design, synthesis, and pharmacological and pharmacokinetic evaluation of 3-phenyl-5-pyridyl-1,2,4-triazole derivatives as xanthine oxidoreductase inhibitors.
    Sato T; Ashizawa N; Iwanaga T; Nakamura H; Matsumoto K; Inoue T; Nagata O
    Bioorg Med Chem Lett; 2009 Jan; 19(1):184-7. PubMed ID: 19027292
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of glycine transporter-1 reduces cue-induced nicotine-seeking, but does not promote extinction of conditioned nicotine cue responding in the rat.
    Cervo L; Di Clemente A; Orrù A; Moro F; Cassina C; Pich EM; Corsi M; Gozzi A; Bifone A
    Addict Biol; 2013 Sep; 18(5):800-11. PubMed ID: 23490434
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and Biological Evaluation of N-((1-(4-(Sulfonyl)piperazin-1-yl)cycloalkyl)methyl)benzamide Inhibitors of Glycine Transporter-1.
    Cioffi CL; Liu S; Wolf MA; Guzzo PR; Sadalapure K; Parthasarathy V; Loong DT; Maeng JH; Carulli E; Fang X; Karunakaran K; Matta L; Choo SH; Panduga S; Buckle RN; Davis RN; Sakwa SA; Gupta P; Sargent BJ; Moore NA; Luche MM; Carr GJ; Khmelnitsky YL; Ismail J; Chung M; Bai M; Leong WY; Sachdev N; Swaminathan S; Mhyre AJ
    J Med Chem; 2016 Sep; 59(18):8473-94. PubMed ID: 27559615
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis of some new 1,3,4-thiadiazol-2-ylmethyl-1,2,4-triazole derivatives and investigation of their antimicrobial activities.
    Demirbas A; Sahin D; Demirbas N; Karaoglu SA
    Eur J Med Chem; 2009 Jul; 44(7):2896-903. PubMed ID: 19167136
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Reactivity of 3-aryl-4-amino-5-mercapto-4H-1,2,4-triazoles: synthesis and biological evaluation of 3,6-diaryl derivatives of 7H-1,2,4-thiazole[3,4-b][1,3,4]thiadiazines, of 3-aryl-4-amino-5-carboxymethylthio-4H-1,2,4-triazoles].
    Mazzone G; Bonina F; Panico AM; Amico-Roxas M; Caruso A; Blandino G; Vanella A
    Farmaco Sci; 1987 Jul; 42(7):525-39. PubMed ID: 2822474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.